Comparative in vitro activity of norfloxacin (MK-0366) and ten other oral antimicrobial agents against urinary bacterial isolates.
about
In vitro activities of norfloxacin and ciprofloxacin against Mycobacterium tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasiiSusceptibility of enterococci to trimethoprim and trimethoprim-sulfamethoxazoleMulticlinic comparative study of norfloxacin and trimethoprim-sulfamethoxazole for treatment of urinary tract infections.Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections.Comparative trial of norfloxacin and trimethoprim-sulfamethoxazole in the treatment of women with localized, acute, symptomatic urinary tract infections and antimicrobial effect on periurethral and fecal microflora.Antimicrobial activity of ciprofloxacin against Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus determined by the killing curve method: antibiotic comparisons and synergistic interactions.Pharmacokinetics of AT-2266 administered orally to mice, rats, dogs, and monkeys.A high performance liquid chromatographic procedure for the simultaneous determination of norfloxacin and furprofen in rat plasma.Multicenter evaluation of the proposed quality control limits and interpretive zone standards for in vitro susceptibility testing with norfloxacinIn vitro activity of WIN 49375 compared with those of other antibiotics in isolates from cancer patientsRecovery of norfloxacin in feces after administration of a single oral dose to human volunteers.Norfloxacin and silver norfloxacin in the treatment of Pseudomonas corneal ulcer in the rabbit.In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent.In vitro antibacterial properties of AT-2266, a new pyridonecarboxylic acid.In vitro and in vivo antibacterial activity of AT-2266.Randomised double-blind study of norfloxacin and cefadroxil in the treatment of acute pyelonephritis.Comparative activities of norfloxacin and fifteen other antipseudomonal agents against gentamicin-susceptible and -resistant Pseudomonas aeruginosa strains.Inappropriate breast secretions of possible bacterial etiology in the parous nonpuerperal female.Pharmacokinetics and tissue residues of norfloxacin and its N-desethyl- and oxo-metabolites in healthy pigs.Norfloxacin vs. pivmecillinam in the treatment of uncomplicated lower urinary tract infections in hospitalized elderly patients.Norfloxacin versus co-trimoxazole for treatment of urinary tract infections in adults: microbiological results of a coordinated multicentre study.
P2860
Q28365998-733628EB-45DB-4FF4-9BEB-5A79EFC9EE0EQ35568914-BD88621A-FB19-4026-A583-EDE131FC6D7FQ35570242-CC3DA777-D10C-4076-BC4F-1FD440C031A0Q35570913-0781E3D6-C812-4775-9D30-E06F0FD7B3CEQ35639946-C6EE110C-BFFC-41AA-A0A4-AF9B00C934DBQ35646442-9D6B6C1A-35B8-4FB0-982C-C213B5F25643Q35748588-0D51C3A6-D917-4AFC-96A1-909E606BBEFAQ36763755-C30C16B3-A3F8-4139-A5DB-E32A12873D88Q37258777-67FAFB82-FDEE-468D-82C7-D2E93E43724FQ39833569-236C8A01-A28D-46EE-8D9A-9468E7ED9BF0Q39848971-82EFDEC2-324F-4610-80C4-1E6884B2FE28Q40087443-ACA06099-34AC-4C34-89D2-C1D90194A646Q41858315-FF9EB033-B2F0-4649-8FF4-2713B7112EFFQ41867252-42D724DE-53ED-4ED5-B915-EF6D0AF5550AQ41952207-C6B787B1-9906-4971-8CC5-8CCFADA5F58DQ42029217-08BAC1F3-4B4A-4D46-AA7C-FD245EC09754Q42929591-27146F21-F0F1-4169-B500-01E89518E2A3Q52027867-BE2B599F-91D5-462B-8B38-FF033C326CF0Q54008697-2D59D17B-B2E4-4048-AA6E-4C699E0C8D8DQ54719261-FB37FF08-EAF0-433B-83E5-30095DB8D2E2Q54769169-0123F200-BD49-461E-AB50-7104971FB9C7
P2860
Comparative in vitro activity of norfloxacin (MK-0366) and ten other oral antimicrobial agents against urinary bacterial isolates.
description
1982 nî lūn-bûn
@nan
1982 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1982 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
name
Comparative in vitro activity ...... st urinary bacterial isolates.
@ast
Comparative in vitro activity ...... st urinary bacterial isolates.
@en
Comparative in vitro activity of norfloxacin
@nl
type
label
Comparative in vitro activity ...... st urinary bacterial isolates.
@ast
Comparative in vitro activity ...... st urinary bacterial isolates.
@en
Comparative in vitro activity of norfloxacin
@nl
prefLabel
Comparative in vitro activity ...... st urinary bacterial isolates.
@ast
Comparative in vitro activity ...... st urinary bacterial isolates.
@en
Comparative in vitro activity of norfloxacin
@nl
P2093
P356
P1476
Comparative in vitro activity ...... st urinary bacterial isolates.
@en
P2093
P2860
P304
P356
10.1128/AAC.21.5.848
P407
P577
1982-05-01T00:00:00Z